Suchergebnisse - "Fajgenbaum, David C"

PubPharm (15)

1

Castleman disease

enthalten in: Nature reviews. Disease primers | 2021

von Carbone, A. | Borok, M. | Damania, B. | +5

2

Is severe COVID-19 a cytokine storm syndrome : a hyperinflammatory debate

enthalten in: Current opinion in rheumatology | 2021

von Mehta, P. | Fajgenbaum, D.

3

Emerging role of 18F-FDG PET/CT in Castleman disease : a review

enthalten in: Insights into imaging | 2021

von Koa, B. | Borja, A. | Aly, M. | +11

4

enthalten in: The New England journal of medicine | 2020

von Fajgenbaum, D. | June, C.

CommentIn: N Engl J Med. 2021 Apr 22;384(16):e59. - PMID 33882214

5

Treatments Administered to the First 9152 Reported Cases of COVID-19 : A Systematic Review

enthalten in: Infectious diseases and therapy | 2020

von Fajgenbaum, D. | Khor, J. | Gorzewski, A. | +19

6

Overview of Castleman disease

enthalten in: Blood | 2020

von Dispenzieri, A. | Fajgenbaum, D.

7

AA amyloidosis associated with Castleman disease : A case report and review of the literature

enthalten in: Medicine | 2020

von Bernabei, L. | Waxman, A. | Caponetti, G. | +2

8

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

9

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

10

Castleman Disease Pathogenesis

enthalten in: Hematology/oncology clinics of North America | 2018

von Fajgenbaum, D. | Shilling, D.